Common Contracts
91 similar Placement Agency Agreement contracts by Inpixon, Medical Transcription Billing, Corp, My Size, Inc., others
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 26th, 2024 • Helius Medical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This letter (the “Agreement”) constitutes the agreement between Craig-Hallum Capital Group LLC (“Craig-Hallum” or the “Placement Agent”) and Helius Medical Technologies, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), that Craig-Hallum shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, for the proposed placement of up to an aggregate of $____ of registered securities of the Company, consisting of up to (i)___________ shares (the “Shares”) of Class A common stock, $0.001 par value per share (the “Common Stock”), and/or (ii) ___________pre-funded Common Stock purchase warrants, each to purchase one share of Common Stock (the “Pre-Funded Warrants,” and the shares issuable upon exercise thereof, the “Pre-Funded Warrant Shares”) at an exercise price of $0.001 per share of Common Stock with each Share and each Pre-Funded Warrant sold together with a Series A Warrant (and defined below) and a Series B Warrant (as d
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 29th, 2024 • Biofrontera Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 2nd, 2023 • Biofrontera Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 17th, 2023 • HeartBeam, Inc. • Surgical & medical instruments & apparatus • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 10th, 2023 • HeartBeam, Inc. • Surgical & medical instruments & apparatus • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 1st, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 17th, 2021 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 12th, 2021 • United States Antimony Corp • Primary smelting & refining of nonferrous metals • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 2nd, 2021 • United States Antimony Corp • Primary smelting & refining of nonferrous metals • New York
PLACEMENT AGENCY AGREEMENT October 22, 2020Placement Agency Agreement • October 27th, 2020 • Iterum Therapeutics PLC • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 21st, 2020 • Iterum Therapeutics PLC • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • August 5th, 2020 • Quest Resource Holding Corp • Services-equipment rental & leasing, nec • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 22nd, 2019 • Invivo Therapeutics Holdings Corp. • Surgical & medical instruments & apparatus • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 20th, 2019 • Phio Pharmaceuticals Corp. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 14th, 2019 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
FORM OF PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 16th, 2019 • Westwater Resources, Inc. • Metal mining • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 3rd, 2018 • China Ceramics Co., LTD • Structural clay products • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), China Ceramics Co., Ltd., a British Virgin islands corporation (the “Company”), hereby agrees to sell up to an aggregate of 1,000,000 registered securities (the “Securities” or “units”) of the Company, including, but not limited to, shares (the “Shares”) of the Company, par value $0.008 per share (the "Common Stock”), and share purchase warrants to purchase up to an aggregate of 500,000 shares of Common Stock (the “Warrants” and, together with the Shares, the “Securities”) directly to various investors (each, an “Investor” and collectively, the “Investors”) through Dawson James Securities, Inc., as placement agent (the “Placement Agent”). The purchase price to the Investors for each unit is $1.27 and the exercise price to the Investors for each share of common stock issuable upon exercise of the Warrants is $1.27. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 10th, 2018 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 9th, 2018 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
CO-PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 17th, 2018 • MoSys, Inc. • Semiconductors & related devices • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 21st, 2018 • Moleculin Biotech, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENT May 17, 2018Placement Agency Agreement • May 22nd, 2018 • Air Industries Group • Aircraft parts & auxiliary equipment, nec • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 24th, 2018 • Inpixon • Services-computer programming services • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 2nd, 2018 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Medical Transcription Billing, Corp., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of 400,000 registered shares (the “Shares”) of the Company’s 11% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value per share (the “Preferred Stock”) (the “Securities”), directly to various investors (each, an “Investor” and, collectively, the “Investors”) through H.C. Wainwright & Co., LLC, as lead placement agent (the “Placement Agent”). The documents executed and delivered by the Company and the Placement Agent, including this Agreement, shall be collectively referred to herein as the “Transaction Documents.” The purchase price to the Investors for each Share is $25.00. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering.
PLACEMENT AGENCY AGREEMENT February 16, 2018Placement Agency Agreement • February 16th, 2018 • Moleculin Biotech, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 16th, 2018 • Inpixon • Services-computer programming services • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 1st, 2018 • Inpixon • Services-computer programming services • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 1st, 2018 • My Size, Inc. • Services-prepackaged software • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 17th, 2018 • Delcath Systems, Inc. • Surgical & medical instruments & apparatus • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 9th, 2018 • Inpixon • Services-computer programming services • New York
PLACEMENT AGENCY AGREEMENT December __, 2017Placement Agency Agreement • December 19th, 2017 • My Size, Inc. • Services-prepackaged software • New York
PLACEMENT AGENCY AGREEMENT December __, 2017Placement Agency Agreement • December 18th, 2017 • My Size, Inc. • Services-prepackaged software • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 12th, 2017 • Air Industries Group • Aircraft parts & auxiliary equipment, nec • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 11th, 2017 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 13th, 2017 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
